icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 22-26 2022
Back grey_arrow_rt.gif
 
 
 
Towards elimination: A clinical and public health approach to control of hepatitis C and B infection in England
 
 
  EASL 2022 June 22-26 London
 
Prof. Graham R Foster
Prof Hepatology QMUL/Barts Health
NHSE Clinical Lead for HCV
 

0706221

0706222

0706223

0706224

0706225

every network has a target & we monitor them on week by week basis.

0706226

0706227

0706228

programs we have initiated.

0706229

07062210

07062211

tough to implement..

07062212

increase in liver cancers in part due to not doing surveillance post cure. all too often patients fall out of the scanning process - with the marginalised groups we are treating follow up attendance is poor. We are trying to address this with a program of out-reach scanning involving community vans with peers, hopefully that will improve things but, I suspect, we are going to see a rise in HCC

07062213

07062214

07062215